Managing cardiovascular related co-morbidities in patients with type 2 diabetes: adopting a multi-factorial approach
These meetings are intended for UK Healthcare Professionals and have been developed in accordance with the ABPI Code of Practice.
PM Healthcare events are Quality Assured by the University of Bradford
| Satellite | Managing cardiovascular related co-morbidities in patients with type 2 diabetes: adopting a multi-factorial approach | |||
| Speakers | Michelle Lam, Specialist Diabetes Pharmacist, St James' Hospital, Leeds | |||
| Satellite Description | ||||
|
This session will focus on how adopting a multi-factorial approach to management of people with type 2 diabetes can improve patient cardiovascular outcomes through lifestyle modification, improved glycaemic control and a reduced risk of micro and macro vascular complications. The importance of tailoring treatment targets and strategies in line with individual patient circumstances will also be discussed. Novo Nordisk has organised and fully funded the 'Managing cardiovascular co-morbidities in patients with type 2 diabetes: adopting a multi-factorial method' symposium for this meeting. Adverse event reporting and prescribing information will be available at this meeting. Date of preparation: July 2017 UK/LE/0717/0011 | ||||
| Sponsored By | Novo Nordisk | |||
